Bolt Biotherapeutics (BOLT) News Today

$1.09

+0.03 (+2.83%)

(As of 02/9/2024 08:56 PM ET)

Source

Source	Headline
	Buy Rating Affirmed for GlycoMimetics Amidst Phase 3 Progress and Breakthrough Therapy Designation for Uproleselan markets.businessinsider.com - January 4 at 7:57 AM
	Bolt Biotherapeutics Enrolls First Patient in Phase 2 Clinical Study Evaluating BDC-1001 in Patients with HER2-Positive Breast Cancer Previously Treated with Enhertu® finance.yahoo.com - December 5 at 7:28 AM
	Promising Clinical Trial Results and Strong Financial Outlook Propel Buy Rating for Bolt Biotherapeutics markets.businessinsider.com - November 11 at 9:52 AM
	Bolt Biotherapeutics Inc Ordinary Shares BOLT morningstar.com - November 9 at 7:45 PM
	Bolt Biotherapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update finance.yahoo.com - November 9 at 7:45 PM
	Bolt Biotherapeutics Presents Updated Clinical Data from Phase 1 Dose-Escalation Trial of BDC-1001 as Monotherapy and in Combination with Nivolumab in HER2-Expressing Tumors at ESMO 2023 Congress finance.yahoo.com - October 23 at 12:45 PM
	Bolt Biotherapeutics Announces First Patient Dosed in Phase 1/2 Study of BDC-3042 in Patients with Advanced Cancers finance.yahoo.com - October 17 at 8:07 AM
	Bolt Biotherapeutics Receives Orphan Drug Designation for BDC-1001 for Treatment of Gastric Cancers finance.yahoo.com - September 28 at 7:54 AM
	Bolt Biotherapeutics to Participate in September Investor Conferences finance.yahoo.com - September 5 at 8:29 PM
	Dynavax Technologies (DVAX) Q2 Earnings and Revenues Surpass Estimates msn.com - August 3 at 8:26 PM
	US0977021049.SG - Bolt Biotherapeutics Inc. finance.yahoo.com - June 17 at 11:56 AM
	Bolt Biotherapeutics (BOLT) Receives a Buy from H.C. Wainwright markets.businessinsider.com - May 26 at 7:38 AM
	SVB Leerink Upgrades Bolt Biotherapeutics (BOLT) msn.com - May 13 at 8:01 AM
	HC Wainwright & Co. Reiterates Bolt Biotherapeutics (BOLT) Buy Recommendation msn.com - May 13 at 8:01 AM
	JonesTrading Reaffirms Their Buy Rating on Bolt Biotherapeutics (BOLT) markets.businessinsider.com - May 12 at 4:20 PM
	Bolt Biotherapeutics, Inc.: Bolt Biotherapeutics Reports First Quarter 2023 Financial Results and Provides Business Update finanznachrichten.de - May 12 at 4:43 AM
	Bolt Biotherapeutics to Present Clinical Data from Phase 1 Dose-Escalation Trial of BDC-1001 in HER2-Expressing Tumors at 2023 ASCO Annual Meeting finance.yahoo.com - April 26 at 1:52 PM
	Investors in Bolt Biotherapeutics (NASDAQ:BOLT) have unfortunately lost 47% over the last year finance.yahoo.com - April 11 at 8:23 AM
	Bolt Biotherapeutics, Inc.: Bolt Biotherapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update finanznachrichten.de - March 30 at 10:05 AM
	Bolt Biotherapeutics to Present Preclinical Data for BDC-3042, a Dectin-2-Targeting Agonistic Antibody, at 2023 AACR Annual Meeting finance.yahoo.com - March 14 at 5:25 PM
	BOLT.O - \| Stock Price & Latest News \| Reuters reuters.com - January 21 at 1:51 PM
	Here's Why We're Watching Bolt Biotherapeutics' (NASDAQ:BOLT) Cash Burn Situation finance.yahoo.com - January 4 at 12:28 PM
	Investors in Bolt Biotherapeutics (NASDAQ:BOLT) have unfortunately lost 89% over the last year finance.yahoo.com - November 2 at 4:10 PM
	Bolt Biotherapeutics to Present at Stifel 2022 Healthcare Conference finance.yahoo.com - November 1 at 10:53 AM
	Bolt Biotherapeutics Inc Ordinary Shares morningstar.com - September 10 at 12:35 AM
	Bolt Biotherapeutics to Present at Morgan Stanley 20th Annual Global Healthcare Conference finance.yahoo.com - August 31 at 11:39 AM
	Bolt Biotherapeutics (NASDAQ:BOLT), Earnings Estimates, EPS, and Revenue benzinga.com - August 12 at 6:36 PM
	The past year for Bolt Biotherapeutics (NASDAQ:BOLT) investors has not been profitable finance.yahoo.com - May 26 at 8:54 AM
	Bolt Biotherapeutics Reports Four Quarter and Full Year 2021 Financial Results and Provides Business Highlights finance.yahoo.com - March 30 at 6:36 PM
	Bolt Biotherapeutics GAAP EPS of -$0.73 misses by $0.04, revenue of $0.51M seekingalpha.com - March 30 at 6:36 PM
	Bolt Biotherapeutics to Present Updates for Three Preclinical Immuno-Oncology Pipeline Programs at AACR Annual Meeting 2022 finance.yahoo.com - March 8 at 7:37 PM
	Bolt Biotherapeutics, Inc. (BOLT) finance.yahoo.com - February 10 at 8:17 PM
	Bolt Biotherapeutics (NASDAQ:BOLT) Downgraded by Zacks Investment Research marketbeat.com - February 7 at 6:20 PM
	Bolt Biotherapeutics to Participate in Upcoming February Conferences finance.yahoo.com - February 2 at 9:03 AM
	Bolt Biotherapeutics Doses First Patient with BDC-1001 in Combination with OPDIVO® (nivolumab) in Ongoing Phase 1/2 Clinical Trial for the Treatment of HER2-Expressing Solid Tumors finance.yahoo.com - January 6 at 10:13 AM
	Morgan Stanley Downgrades Bolt Biotherapeutics (NASDAQ:BOLT) to Equal Weight marketbeat.com - January 6 at 8:17 AM
	Bolt Biotherapeutics, Inc. (NASDAQ:BOLT) Given Average Recommendation of "Buy" by Analysts marketbeat.com - January 2 at 6:21 AM
	Bolt Biotherapeutics Shares Rise 12% After CFO Buys 5,000 Shares marketwatch.com - December 11 at 11:03 PM
	Bolt Biotherapeutics Stock Halves on Mediocre Trial Data finance.yahoo.com - December 6 at 5:33 PM
	Why Bolt Biotherapeutics Stock Crashed Today finance.yahoo.com - December 6 at 5:33 PM
	Bolt Biotherapeutics Interim Data Shows BDC-1001 Cancer Treatment Well-Tolerated marketwatch.com - December 6 at 7:32 AM
	Bolt Biotherapeutics Reports Interim BDC-1001 Phase 1/2 Data Demonstrating a Safe and Well-tolerated Profile and Emerging Clinical Activity at the ESMO Immuno-Oncology Congress 2021 finance.yahoo.com - December 6 at 7:32 AM
	Bolt Biotherapeutics Announces Changes to its Board of Directors finance.yahoo.com - November 19 at 8:13 AM
	Bolt Biotherapeutics Presents New Preclinical Data on Three Pipeline Programs at Society for Immunotherapy of Cancer (SITC) Annual Meeting finance.yahoo.com - November 12 at 8:34 AM
	Bolt Biotherapeutics Reports Third Quarter 2021 Financial Results and Provides Business Highlights finance.yahoo.com - November 9 at 7:44 AM
	Bolt Biotherapeutics to Present Updates on Three Pipeline Programs at the 2021 Society for ... apnews.com - October 2 at 4:40 AM
	Bolt Biotherapeutics to Present Updates on Three Pipeline Programs at the 2021 Society for Immunotherapy of Cancer Annual Meeting (SITC) finance.yahoo.com - October 1 at 8:36 AM
	BRIEF-Bolt Biotherapeutics And Innovent Biologics Announce Collaboration msn.com - August 26 at 9:07 PM
	Companies Like Bolt Biotherapeutics (NASDAQ:BOLT) Are In A Position To Invest In Growth nasdaq.com - August 16 at 7:52 AM
	Here's Why We're Not Too Worried About Bolt Biotherapeutics' (NASDAQ:BOLT) Cash Burn Situation finance.yahoo.com - August 16 at 7:52 AM

Get Bolt Biotherapeutics News Delivered to You Automatically

BOLT Media Mentions By Week

BOLT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BOLT
News Sentiment
▼
1.89

0.92
▲
Average
Medical
News Sentiment

BOLT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BOLT Articles
This Week
▼
1

0
▲
BOLT Articles
Average Week

Get Bolt Biotherapeutics News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:BOLT) was last updated on 2/12/2024 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Bolt Biotherapeutics (BOLT) News Today

BOLT Media Mentions By Week

BOLT Media Sentiment

BOLT News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info